Panmure Gordon (UK) Limited, an exempt principal trader, has disclosed its dealings in the securities of Allergy Therapeutics plc. On August 10, 2023, Panmure Gordon purchased 542,613 0.1p ordinary shares at a price range of 0.02365 to 0.02511 per unit. No sales were made. The disclosure does not include any cash-settled derivative transactions or stock-settled derivative transactions. No indemnity or option arrangements, agreements, or understandings relating to relevant securities were reported. The disclosure was made in accordance with Rule 8 of the Takeover Code.